Journals / Adli Tıp Dergisi / 2021 / Cilt: 35 Sayı: 3

Neurocognitive disorder in forensic psychiatry: A retrospective single center study

Adli psikiyatride nörobilişsel bozukluk: Retrospektif tek merkezli bir çalışma

Ender Cesur(Department of Psychiatry, Acıbadem Maslak Hospital, Istanbul, Turkiye)
Zerrin Yıldırım(Department of Neurology, Bağcılar Research and Training Hospital, Istanbul, Turkiye)
İlker Taşdemir(Observation Specialization Department, The Council of Forensic Medicine, Istanbul, Turkiye)
Fatma Nuray Cansunar(Forensic Medicine Fourth Specialization Board, The Council of Forensic Medicine, Istanbul, Turkiye)
Pages
176–185
Publication Date
2021-12-31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There is a significant difference between the groups in terms of reason for evaluation and decision p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:INTRODUCTION: To define the clinical and forensic characteristics of patients who are evaluated in terms of forensic psychiatry and who have neurocognitive disorders and to contribute to clinicians in approaching patients.METHODS: For the study, the data of people who were evaluated by the Forensic Medicine Fourth Specialization Board and who were found to have neurocognitive disorders dementia, mild cognitive impairment MCI , organic mental disorder OMD were scanned retrospectively.RESULTS: Two-hundered one patients were included in the study.
📊
Key Findings & Data:Of the patients, 80.1% were diagnosed with dementia, whereas 14.9% were diagnosed with MCI and 5% were diagnosed with OMD.
💡
Conclusion & Impact:There is a significant difference between the groups in terms of reason for evaluation and decision p
🔬Design:Araştırma Makalesi
📍Scope:Comprehensive Sample
⚙️Variables:Nörobilişsel bozukluk · demans · hafif bilişsel bozukluk

Abstract

INTRODUCTION: To define the clinical and forensic characteristics of patients who are evaluated in terms of forensic psychiatry and who have neurocognitive disorders and to contribute to clinicians in approaching patients.METHODS: For the study, the data of people who were evaluated by the Forensic Medicine Fourth Specialization Board and who were found to have neurocognitive disorders dementia, mild cognitive impairment MCI , organic mental disorder OMD were scanned retrospectively.RESULTS: Two-hundered one patients were included in the study. Of the patients, 80.1% were diagnosed with dementia, whereas 14.9% were diagnosed with MCI and 5% were diagnosed with OMD. There is a significant difference between the groups in terms of reason for evaluation and decision p

Özet

AMAÇ: Adli psikiyatrik açıdan değerlendirilen ve nörobilişsel bozukluk saptanan hastaların klinik ve adli özelliklerini tanımlamak ve bu kişilere yaklaşım konusunda klinisyenlere katkı sağlamaktır. YÖNTEM: Çalışma için, Adli Tıp Dördüncü İhtisas Kurulu tarafından değerlendirilen ve değerlendirme sonucunda nörobilişsel bozukluk demans, hafif bilişsel bozukluk HBB , organik mental bozukluk OMB saptanan kişilerin verileri geriye dönük olarak taranmıştır. BULGULAR: Çalışmaya 201 hasta dahil edilmiştir. Hastaların %80,1’i demans, %14,9’u HBB ve %5’i OMB tanısı almıştır. Gruplar arasında değerlendirilme nedeni ve karar p

🔖

Cite This Article

Cesur, E., Yıldırım, Z., Taşdemir, İ., Cansunar, F. N. (2021). Neurocognitive disorder in forensic psychiatry: A retrospective single center study. Adli Tıp Dergisi, Cilt: 35 Sayı: 3, 176–185. https://ajindex.com/articles/1352525

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (38)

  1. First MB, Williams JBW, Karg RS, Spitzer RL. User’s Guide for the Structured Clinical Interview for DSM-5 Disorders, Research Version. Arlington, VA, American Psychiatric Associa- tion, 2015.
  2. Bozoğlu E. Mild Cognitive Impariment. Turkiye Klinikleri J Geriatr-Special Topics 2017;3 1:73-80.
  3. Ekström A, Kristiansson M, Björkstén KS. Dementia and cognitive disorder identified at a forensic psychiatric examination - a study from Sweden. BMC Geriatrics 2017;17:219.
  4. Mitchell AJ, Shiri-Feshki M. Rate of progression of mild cognitive impairment to dementia-meta-analysis 16. of 41 robust inception cohort studies. Acta Psychiatr Scand;119 4:252-65.
  5. Gurvit IH, Baran B. Scales in dementia and cognitive disorders. Arch Neuropsychiatry 2007;44:58-65.
  6. Olkinuora M. Organic brain syndromes from a psy- chiatric point of view: diagnostic and nosological aspects. Acta Neurol Scand Suppl. 1982;92:47-57.
  7. Petersen RC. Mild cognitive impairment. Dementia;10:9-28.
  8. Arias JJ, Flicker LS. A Matter of Intent: A Social Obli- gation to Improve Criminal Procedures for Individuals with De- mentia. The Journal of Law, Medicine & Ethics 2020;48 2:318-27.
  9. Liljegren M, Naasan G, Temlett J, Perry DC, Rankin KP, Merrilees J, Grinberg LT, Seeley WW, Englund E, Miller BL. Criminal behavior in frontotemporal dementia and Alzheimer disease. JAMA Neurol 2015;72 3:295-300.
  10. Hegde S, Ellajosyula R. Capacity issues and decisionmaking in dementia. Ann Indian Acad Neurol 2016;19 1:34-9.
  11. Kulu M, Özsoy F. Guardianship reports given by disableds’ health board. Bozok Med J 2019;9 2:6-10.
  12. Gürvit İH, Yıldırım Z. Alzheimer Hastalığı. Öge AE, Baykan B, Bilgiç B editörler. Nöroloji Kitabı [in Turkish]. İstanbul: Nobel Tıp Kitabevleri, 2021; 589-617.
  13. Goodman RA, Lochner KA, Thambisetty M, Wingo TS, Posner SF, Ling SM. Prevalence of dementia subtypes in United States Medicare fee-for-service beneficiaries, 2011-2013. Alzheimers Dement 2017;13 1:28-37.
  14. Peterson RC. Mild Cognitive Impairment. N Engl J Med. 2011;364 23:2227-34.
  15. Jolley D, Baxter D. Life expectation in organic brai disease. Advances in Psychiatric Treatment 1997;3 4:211-8.
  16. Kane MN. Legal guardianship and other alternatives in the care of elders with Alzheimer’s disease. Am J Alzheimers Dis Other Demen 2001;16 2:89-96.
  17. Nnatu IO, Mahomed F, Shah A. Is there a need for elderly forensic psychiatric services? Med Sci Law 2005;45 2:154- 60.
  18. Yıldız A. To be 65 years old in Turkey: Is it the end of being an individual and competent? Turkish Journal of Bioethics 2018;5 3:117-25.
  19. Sağlık Kurulunda Demans, Turkish Neurology Association, 2019. Available at: https://www.noroloji.org.tr/TNDData/ Uploads/files/DEMANS%20BASKI%20.pdf [in Turkish] cited: 15.12.2021.
  20. Gülmez Ö, Tümer AR, Karacaoğlu E, Akçan R, Balseven Odabaşı A. Legal Capacity in Alzheimer’s Disease. Sted 2014;23 1:30-8.
  21. Pandey P, Varshney P, Gajera GV, Nirisha PL, Malathesh BC, Manjunatha N, Sivakumar PT, Kumar CN, Math SB. Criminal Responsibility in Geropsychiatry: Competence, Culpability, and Care. Indian J Psychol Med 2021;43 5:97-106.
  22. Bozoğlu E. Mild Cognitive Impariment. Turkiye Klinikleri J Geriatr-Special Topics 2017;3 1:73-80.
  23. Mitchell AJ, Shiri-Feshki M. Rate of progression of mild cognitive impairment to dementia-meta-analysis 16. of 41 robust inception cohort studies. Acta Psychiatr Scand;119 4:252-65.
  24. Petersen RC. Mild cognitive impairment. Dementia;10:9-28.
  25. Arias JJ, Flicker LS. A Matter of Intent: A Social Obli- gation to Improve Criminal Procedures for Individuals with De- mentia. The Journal of Law, Medicine & Ethics 2020;48 2:318-27.
  26. Liljegren M, Naasan G, Temlett J, Perry DC, Rankin KP, Merrilees J, Grinberg LT, Seeley WW, Englund E, Miller BL. Criminal behavior in frontotemporal dementia and Alzheimer disease. JAMA Neurol 2015;72 3:295-300.
  27. Hegde S, Ellajosyula R. Capacity issues and decisionmaking in dementia. Ann Indian Acad Neurol 2016;19 1:34-9.
  28. Kulu M, Özsoy F. Guardianship reports given by disableds’ health board. Bozok Med J 2019;9 2:6-10.
  29. Gürvit İH, Yıldırım Z. Alzheimer Hastalığı. Öge AE, Baykan B, Bilgiç B editörler. Nöroloji Kitabı [in Turkish]. İstanbul: Nobel Tıp Kitabevleri, 2021; 589-617.
  30. Goodman RA, Lochner KA, Thambisetty M, Wingo TS, Posner SF, Ling SM. Prevalence of dementia subtypes in United States Medicare fee-for-service beneficiaries, 2011-2013. Alzheimers Dement 2017;13 1:28-37.
  31. Peterson RC. Mild Cognitive Impairment. N Engl J Med. 2011;364 23:2227-34.
  32. Jolley D, Baxter D. Life expectation in organic brai disease. Advances in Psychiatric Treatment 1997;3 4:211-8.
  33. Kane MN. Legal guardianship and other alternatives in the care of elders with Alzheimer’s disease. Am J Alzheimers Dis Other Demen 2001;16 2:89-96.
  34. Nnatu IO, Mahomed F, Shah A. Is there a need for elderly forensic psychiatric services? Med Sci Law 2005;45 2:154- 60.
  35. Yıldız A. To be 65 years old in Turkey: Is it the end of being an individual and competent? Turkish Journal of Bioethics 2018;5 3:117-25.
  36. Sağlık Kurulunda Demans, Turkish Neurology Association, 2019. Available at: https://www.noroloji.org.tr/TNDData/ Uploads/files/DEMANS%20BASKI%20.pdf [in Turkish] cited: 15.12.2021.
  37. Gülmez Ö, Tümer AR, Karacaoğlu E, Akçan R, Balseven Odabaşı A. Legal Capacity in Alzheimer’s Disease. Sted 2014;23 1:30-8.
  38. Pandey P, Varshney P, Gajera GV, Nirisha PL, Malathesh BC, Manjunatha N, Sivakumar PT, Kumar CN, Math SB. Criminal Responsibility in Geropsychiatry: Competence, Culpability, and Care. Indian J Psychol Med 2021;43 5:97-106.